Latest Staphylococcus aureus Stories
Unique Phenotypic Targeting Approach Provides Physicians with a Better, Faster Way to Identify MRSA and MSSA WOBURN, Mass., Nov.
LONDON, November 5, 2014 /PRNewswire/ -- - Endolysin Staphefekt(TM) shown to kill Staphylococcus aureus, including MRSA - Emergence of
Antimicrobial patient and staff stations installed into Western Australian private hospital, capable of a biocidal kill rate of 99% against deadly infections and superbugs. Perth,
VIENNA and PHILADELPHIA, October 8, 2014 /PRNewswire/ -- Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics
Topical report “Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014” worked out by Global Markets Direct is now available at MarketPublishers.com.
Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct.
Transmission of bacterial infections, including MRSA and MSSA could be curbed by coating hospital surfaces with microscopic bumps that mimic the scaly surface of shark skin, according to research published in the open access journal Antimicrobial Resistance and Infection Control.
CHICAGO, Sept. 17, 2014 /PRNewswire-USNewswire/ -- "MRSA is the number one pathogen that is killing patients in U.S.
Clearstream officials comment on this growing health threat – MRSA and the growing list of infections that abound in hospitals nationwide, which Clearstream maintains can be reduced with advanced
Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...
- A political dynamiter.